ArticlebioRxiv : the preprint server for biology2025
BAG3 modulates clathrin-mediated endocytosis and tau uptake in astrocytes.
Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Updated by
Authors and funding
5 authors.
Funding
Abstract
In a healthy brain, astrocytes maintain neuronal homeostasis by removing proteins like tau from the extracellular space, preventing their uptake by neurons. In Alzheimer's disease (AD), this function is impaired, contributing to tau accumulation. Many AD risk genes are linked to endocytosis pathways, suggesting their role in AD pathogenesis. Astrocytes can internalize, degrade, and release tau, but the mechanisms remain unclear. BAG3, a multifunctional protein, regulates vacuolar processes and interacts with clathrin-mediated endocytosis (CME) components. However, its role in astrocytic CME and tau processing is not fully understood. We show BAG3 depletion in astrocytes reduces clathrin-AP-2 interaction, inhibits CME-dependent epidermal growth factor receptor internalization, and decreases tau uptake. Live-cell imaging reveals BAG3 depletion impairs CME dynamics, increasing clathrin particle lifetimes. BAG3 depletion also alters endolysosomal compartments, increasing Lamp1+ puncta and tau co-localization. These findings highlight BAG3's role in CME, tau trafficking, and vacuolar processes, suggesting its dysfunction may contribute to AD pathogenesis.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.